📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials (2023)

First Author: Ciani O

Attributed to: Reporting of randomised trials using surrogate outcomes: development of extensions to the CONSORT 2010 and SPIRIT 2013 guidance statements funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2023.102283

PubMed Identifier: 37877001

Publication URI: http://europepmc.org/abstract/MED/37877001

Type: Journal Article/Review

Parent Publication: eClinicalMedicine

ISSN: 2589-5370